196 related articles for article (PubMed ID: 2579616)
21. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
van Kammen DP; van Kammen WB; Mann LS; Seppala T; Linnoila M
Arch Gen Psychiatry; 1986 Oct; 43(10):978-83. PubMed ID: 3753162
[TBL] [Abstract][Full Text] [Related]
22. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
Sedvall GC; Wode-Helgodt B
Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
[TBL] [Abstract][Full Text] [Related]
23. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles.
Potkin SG; Weinberger DR; Linnoila M; Wyatt RJ
Am J Psychiatry; 1983 Jan; 140(1):21-5. PubMed ID: 6183980
[TBL] [Abstract][Full Text] [Related]
24. Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy.
Cazzullo CL; Vita A; Sacchetti E; Dieci M; Giobbio M; Valvassori G
Psychiatry Res; 1989 Sep; 29(3):257-9. PubMed ID: 2608769
[No Abstract] [Full Text] [Related]
25. CSF creatinine in schizophrenia.
Swahn CG; Sedvall G
Biol Psychiatry; 1988 Mar; 23(6):586-94. PubMed ID: 2451543
[TBL] [Abstract][Full Text] [Related]
26. Quantitative computed tomographic study in schizophrenia: cerebral density and ventricle measures.
Rossi A; Stratta P; D'Albenzio L; Di Michele V; Serio A; Giordano L; Petruzzi C; Casacchia M
Psychol Med; 1989 May; 19(2):337-42. PubMed ID: 2762438
[TBL] [Abstract][Full Text] [Related]
27. Cerebellar morphology in chronic schizophrenic patients: a controlled computed tomography study.
Dewan MJ; Pandurangi AK; Lee SH; Ramachandran T; Levy BF; Boucher M; Yozawitz A; Major L
Psychiatry Res; 1983 Oct; 10(2):97-103. PubMed ID: 6581493
[TBL] [Abstract][Full Text] [Related]
28. Relationships between brain density, cortical atrophy and ventriculomegaly in schizophrenia and mania.
Coffman JA; Nasrallah HA
Acta Psychiatr Scand; 1985 Aug; 72(2):126-32. PubMed ID: 4050505
[TBL] [Abstract][Full Text] [Related]
29. Computed tomography in schizophreniform disorder and other acute psychiatric disorders.
Weinberger DR; DeLisi LE; Perman GP; Targum S; Wyatt RJ
Arch Gen Psychiatry; 1982 Jul; 39(7):778-83. PubMed ID: 6984643
[TBL] [Abstract][Full Text] [Related]
30. Cerebral atrophy and neuropsychological correlates in schizophrenia.
Rossi A; de Cataldo S; Stratta P; Sabatini MD; Nistico R; De Donatis M; Casacchia M
Acta Psychiatr Belg; 1987; 87():670-5. PubMed ID: 3452986
[TBL] [Abstract][Full Text] [Related]
31. Computerized axial tomography scans and subtypes of schizophrenia. A review of the literature.
Goetz KL; van Kammen DP
J Nerv Ment Dis; 1986 Jan; 174(1):31-41. PubMed ID: 3510269
[TBL] [Abstract][Full Text] [Related]
32. Cortical and subcortical computed tomographic study in schizophrenia.
Rossi A; Stratta P; de Cataldo S; Di Michele V; Orfanelli G; Serio A; Petruzzi C; Casacchia M
J Psychiatr Res; 1988; 22(2):99-105. PubMed ID: 3404483
[TBL] [Abstract][Full Text] [Related]
33. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.
Pfefferbaum A; Zipursky RB; Lim KO; Zatz LM; Stahl SM; Jernigan TL
Arch Gen Psychiatry; 1988 Jul; 45(7):633-40. PubMed ID: 3382323
[TBL] [Abstract][Full Text] [Related]
34. Choice of comparison group and findings of computerised tomography in schizophrenia.
Smith GN; Iacono WG; Moreau M; Tallman K; Beiser M; Flak B
Br J Psychiatry; 1988 Nov; 153():667-74. PubMed ID: 3267143
[TBL] [Abstract][Full Text] [Related]
35. Ventricular and sulcal size at the onset of psychosis.
Iacono WG; Smith GN; Moreau M; Beiser M; Fleming JA; Lin TY; Flak B
Am J Psychiatry; 1988 Jul; 145(7):820-4. PubMed ID: 3381925
[TBL] [Abstract][Full Text] [Related]
36. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
Jennings WS; Schulz SC; Narasimhachari N; Hamer RM; Friedel RO
Psychiatry Res; 1985 Oct; 16(2):87-94. PubMed ID: 2415997
[TBL] [Abstract][Full Text] [Related]
37. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
38. Clinical correlates of sulcal widening in chronic schizophrenia.
Nasrallah HA; Kuperman S; Jacoby CG; McCalley-Whitters M; Hamra B
Psychiatry Res; 1983 Dec; 10(4):237-42. PubMed ID: 6583714
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients.
Nyman H; Nybäck H; Wiesel FA; Oxenstierna G; Schalling D
Acta Psychiatr Scand; 1986 Sep; 74(3):292-301. PubMed ID: 3788656
[TBL] [Abstract][Full Text] [Related]
40. Schizophrenic dementia. Clinical and computed axial tomography correlates.
Lawson WB; Waldman IN; Weinberger DR
J Nerv Ment Dis; 1988 Apr; 176(4):207-12. PubMed ID: 3351499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
